Cure My Disease

Don't miss your cure!

 Log in / Sign up

New 'Double-Target' drug enters human trials for Tough-to-Treat cancers

NCT ID NCT05958121

Recruiting now Disease control Sponsor: Immatics Biotechnologies GmbH Source: ClinicalTrials.gov ↗

Summary

This trial is testing a new, first-of-its-kind drug called IMA402 in adults with advanced solid tumors that have come back or stopped responding to all standard treatments. The main goals are to find a safe dose and see if the drug can shrink tumors. The study will enroll about 145 participants to evaluate safety and early signs of effectiveness.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antoni von Leeuwenhoek- Netherlands Cancer Institute

    RECRUITING

    Amsterdam, North Holland, 1066 CX, Netherlands

  • Elbe Kliniken Stade- Buxtehude Elbe Klinikum Buxtehude gGmbH

    RECRUITING

    Buxtehude, Lower Saxony, 21614, Germany

  • Johannes Wesling Klinikum Minden

    RECRUITING

    Minden, North Rhine-Westphalia, 32429, Germany

  • Justus-Liebig-Universitaet Giessen

    RECRUITING

    Giessen, Hesse, 35392, Germany

  • KEM I Evang. Kliniken Essen-Mitte gGmbH

    RECRUITING

    Essen, North Rhine-Westphalia, 45136, Germany

  • Klinikum Chemnitz gGmbH

    RECRUITING

    Chemnitz, Saxony, 09116, Germany

  • Klinikum Nürnberg

    RECRUITING

    Nuremberg, Bavaria, 90419, Germany

  • Leiden Universitair Medisch Centrum

    RECRUITING

    Leiden, South Holland, 2333 ZA, Netherlands

  • Marien Hospital Duesseldorf GmbH

    RECRUITING

    Düsseldorf, North Rhine-Westphalia, 40479, Germany

  • Philipps-Universitaet Marburg

    RECRUITING

    Marburg, Hesse, 35043, Germany

  • Universitaet Muenster

    NOT_YET_RECRUITING

    Münster, North Rhine-Westphalia, 48149, Germany

  • Universitaetsklinikum Bonn AöR

    RECRUITING

    Bonn, North Rhine-Westphalia, 53127, Germany

  • Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR

    RECRUITING

    Dresden, Saxony, 01307, Germany

  • Universitaetsklinikum Erlangen AöR

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

  • Universitaetsklinikum Essen AöR

    RECRUITING

    Essen, North Rhine-Westphalia, 45147, Germany

  • Universitaetsklinikum Heidelberg AöR

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Universitaetsklinikum Magdeburg AöR

    RECRUITING

    Magdeburg, Saxony-Anhalt, 39120, Germany

  • Universitaetsklinikum Mannheim GmbH

    RECRUITING

    Mannheim, Baden-Wurttemberg, 68167, Germany

  • Universitaetsklinikum Regensburg

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Universitaetsklinikum Ulm AöR

    RECRUITING

    Ulm, Baden-Wurttemberg, 89081, Germany

  • Universitaetsklinikum Wuerzburg AöR

    RECRUITING

    Würzburg, Bavaria, 97080, Germany

  • Universitair Medisch Centrum Groningen

    RECRUITING

    Groningen, 9713 GZ, Netherlands

  • Universitair Medisch Centrum Utrecht

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • University Of Leipzig

    RECRUITING

    Leipzig, Saxony, 04103, Germany

Conditions

Explore the condition pages connected to this study.

CANCER RECURRENT CANCER REFRACTORY CANCER SOLID TUMOR, ADULT